Pharmaceuticals

Genetic Analysis Market Forecast 2026–2035: Data Trends and Industry Insights

February 16, 2026February 16, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the genetic analysis market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Genetic Analysis Market be in 2030 compared with 2026?

The genetic analysis market has experienced rapid expansion in recent years. It is anticipated to increase from $10.29 billion in 2025 to $11.63 billion in 2026, at a compound annual growth rate (CAGR) of 13.0%. The growth observed in prior periods can be attributed to elements such as the constrained accessibility of high-throughput sequencing platforms, the continued use of conventional genetic testing methods, a growing understanding of genetic disorders, enhanced investment in research laboratories, and an increasing proliferation of diagnostic centers.

The genetic analysis market size is anticipated to experience substantial expansion over the next few years. This market is projected to reach $18.75 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.7%. The growth during the forecast period is primarily driven by improvements in ngs and real-time pcr technologies, the development of cloud-based genomic data platforms, the increasing adoption of personalized medicine, rising government initiatives for genetic disease screening, and the integration of ai and bioinformatics tools in diagnostics. Significant trends anticipated in this period include the broadening scope of next-generation sequencing (ngs) and pcr-based genetic testing, the growing uptake of pharmacogenomic testing for personalized medicine, an increase in prenatal and newborn genetic screening programs, a heightened focus on rare disease and cancer genetic diagnostics, and the incorporation of bioinformatics and genomic data analysis tools.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27295&type=smp

What Drivers Are Guiding Growth Patterns In The Genetic Analysis Market?

The escalating incidence of cancer is projected to drive the growth of the genetic analysis market. Cancer, a condition marked by the uncontrollable proliferation of certain cells in the body and their potential to spread, is becoming more prevalent. This rise is attributed to an aging population, as older individuals are more susceptible to accumulating genetic mutations and have prolonged exposure to environmental and lifestyle risk factors contributing to cancer development. Genetic analysis proves beneficial for cancer by identifying specific genetic mutations that cause the disease, allowing doctors to select more effective targeted treatments with fewer side effects. For example, a report published by the National Cancer Institute (NCI) in May 2025 revealed that roughly 20 million people worldwide were newly diagnosed with cancer in 2022, and approximately 9.7 million died from it. Forecasts indicate that by 2050, the annual number of new cancer cases could reach 33 million, with cancer-related deaths expected to increase to 18.2 million. Thus, the increasing cases of cancer are a significant driver for the expansion of the genetic analysis market.

Which Segments Are Driving Activity In The Genetic Analysis Market?

The genetic analysis market covered in this report is segmented –

1) By Product: Reagents And Kits, Instruments, Software

2) By Test: Predictive Genetic Testing, Carrier Testing, Prenatal And Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing, Other Tests

3) By Technology: Next-Generation Sequencing (NGS), Real-Time PCR System, Other Technologies

4) By Application: Cancer, Genetic Diseases, Cardiovascular Diseases, Rare Diseases, Infectious Diseases, Other Applications

5) By End-Use: Hospitals, Research And Development Laboratories, Diagnostic Centers, Other End-Uses

Subsegments:

1) By Reagents And Kits: DNA Extraction Kits, RNA Extraction Kits, PCR Reagents, Sequencing Reagents, Library Preparation Kits, Electrophoresis Reagents, Microarray Kits, Genotyping Assay Kits, Target Enrichment Kits, Nucleic Acid Labeling Kits

2) By Instruments: DNA Sequencers, PCR Machines, Microarray Scanners, Electrophoresis Systems, Real-Time PCR Systems, Automated Sample Preparation Systems, Genetic Analyzers, Bioanalyzers, Fragment Analyzers, Next-Generation Sequencing (NGS) Platforms

3) By Software: Data Analysis Software, Bioinformatics Tools, Laboratory Information Management Systems (LIMS), Genomic Data Interpretation Software, DNA Sequence Alignment Tools, Variant Annotation Software, Clinical Decision Support Software, Cloud-Based Genomic Platforms, Workflow Management Software, Data Visualization Tools

Which Trends Are Influencing The Development Of The Genetic Analysis Market?

Leading companies in the genetic analysis market are concentrating on creating advanced offerings, such as genetic testing solutions, to facilitate preventive measures or early monitoring. Genetic testing solutions involve examining an individual’s DNA to identify changes or variations in genes that may be linked to specific health conditions or inherited traits. For example, in June 2023, Devyser, a Sweden-based firm specializing in diagnostic kit development, introduced Devyser LynchFAP and Devyser BRCA PALB2, two genetic testing solutions designed for hereditary cancer. Devyser LynchFAP is distinct for providing a complete solution for analyzing PMS2 and nine additional genes associated with hereditary colorectal cancer, effectively resolving the complex challenge of distinguishing PMS2 from its pseudogene PMS2CL. It represents the first commercial kit specifically engineered for precise analysis of the PMS2 gene. Devyser BRCA PALB2 enables targeted detection of genetic variants in BRCA1, BRCA2, and PALB2, which are critical genes linked to an increased risk of breast and ovarian cancer. Its user-friendly design allows for quick integration into lab workflows and supports DNA analysis from both blood and tumor samples within a single test.

Which Leading Companies Dominate The Genetic Analysis Market Share?

Major companies operating in the genetic analysis market are Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Quest Diagnostics Inc., Illumina Inc., PerkinElmer Inc., BioRad Laboratories Inc., Qiagen NV, Oxford Nanopore Technologies Plc, 23andMe Inc., ELITech Group, MyHeritage Ltd., Dante Labs Inc., AutoGenomics Inc., IntegraGen SA, Family Tree DNA, 24 genetics, Centrillion Biosciences Inc., DNA Worldwide Group Ltd., Genebase.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/genetic-analysis-global-market-report

How Does The Genetic Analysis Market Perform Across Major Global Regions?

North America was the largest region in the genetic analysis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Genetic Analysis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27295&type=smp

Browse Through More Reports Similar to the Global Genetic Analysis Market 2026, By The Business Research Company

Scanner Market Report 2026

https://www.thebusinessresearchcompany.com/report/scanner-global-market-report

Scanner Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/scanner-software-global-market-report

Document Scanning Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/document-scanning-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795